Samarium

DB12403InvestigationalSmall molecule

Samarium has been used in trials studying the treatment and prevention of Pain, Cancer, Metastasis, Prostate Cancer, and Metastatic Osteosarcoma, among others.

Chemical structure of Samarium
Formula / weight
Sm · 150.36 g/mol (avg)

Resolves to

Compound
UNII42OD65L39FCAS7440-19-9ChEBI33374PubChem23951
Clinical / RWD
RxNorm9549
Structure
InChIKeyKZUNJOHGWZRPMI-UHFFFAOYSA-NSMILES[Sm]
Targets
P35243RCVRN

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Samarium, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In